array:22 [ "pii" => "S0210480605732939" "issn" => "02104806" "doi" => "10.1016/S0210-4806(05)73293-9" "estado" => "S300" "fechaPublicacion" => "2005-01-01" "aid" => "73293" "copyright" => "Asociación Española de Urología (AEU)" "copyrightAnyo" => "2005" "documento" => "article" "crossmark" => 0 "subdocumento" => "fla" "cita" => "Actas Urol Esp. 2005;29:535-41" "abierto" => array:3 [ "ES" => false "ES2" => false "LATM" => false ] "gratuito" => false "lecturas" => array:2 [ "total" => 1103 "formatos" => array:3 [ "EPUB" => 7 "HTML" => 739 "PDF" => 357 ] ] "itemSiguiente" => array:18 [ "pii" => "S0210480605732940" "issn" => "02104806" "doi" => "10.1016/S0210-4806(05)73294-0" "estado" => "S300" "fechaPublicacion" => "2005-01-01" "aid" => "73294" "copyright" => "Asociación Española de Urología (AEU)" "documento" => "article" "crossmark" => 0 "subdocumento" => "fla" "cita" => "Actas Urol Esp. 2005;29:542-9" "abierto" => array:3 [ "ES" => false "ES2" => false "LATM" => false ] "gratuito" => false "lecturas" => array:2 [ "total" => 921 "formatos" => array:3 [ "EPUB" => 5 "HTML" => 575 "PDF" => 341 ] ] "es" => array:10 [ "idiomaDefecto" => true "titulo" => "Prostatectomía radical. Revisión de nuestra serie en el periodo 1997-2003" "tienePdf" => "es" "tieneTextoCompleto" => 0 "tieneResumen" => array:2 [ 0 => "es" 1 => "en" ] "paginas" => array:1 [ 0 => array:2 [ "paginaInicial" => "542" "paginaFinal" => "549" ] ] "titulosAlternativos" => array:1 [ "en" => array:1 [ "titulo" => "Radical prostatectomy. A review of our serie between 1997-2003" ] ] "contieneResumen" => array:2 [ "es" => true "en" => true ] "contienePdf" => array:1 [ "es" => true ] "autores" => array:1 [ 0 => array:2 [ "autoresLista" => "F. Aguiló Lucia, J.F. Suárez Novo, J. Planes Morín, E. Condom Mundó" "autores" => array:4 [ 0 => array:2 [ "nombre" => "F." "apellidos" => "Aguiló Lucia" ] 1 => array:2 [ "nombre" => "J.F." "apellidos" => "Suárez Novo" ] 2 => array:2 [ "nombre" => "J." "apellidos" => "Planes Morín" ] 3 => array:2 [ "nombre" => "E." "apellidos" => "Condom Mundó" ] ] ] ] ] "idiomaDefecto" => "es" "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S0210480605732940?idApp=UINPBA00004N" "url" => "/02104806/0000002900000006/v1_201304251755/S0210480605732940/v1_201304251755/es/main.assets" ] "es" => array:13 [ "idiomaDefecto" => true "titulo" => "Utilidad clínica del test urinario Immunocyt<span class="elsevierStyleSup">TM</span> en el protocolo de revisiones de pacientes con antecedentes de neoplasia uroteliales" "tieneTextoCompleto" => 0 "paginas" => array:1 [ 0 => array:2 [ "paginaInicial" => "535" "paginaFinal" => "541" ] ] "autores" => array:1 [ 0 => array:4 [ "autoresLista" => "C. García Peñalver, A. Pérez Barrios, O. Leiva Galvis" "autores" => array:3 [ 0 => array:3 [ "nombre" => "C." "apellidos" => "García Peñalver" "referencia" => array:1 [ 0 => array:2 [ "etiqueta" => "<span class="elsevierStyleSup">1</span>" "identificador" => "cor0005" ] ] ] 1 => array:2 [ "nombre" => "A." "apellidos" => "Pérez Barrios" ] 2 => array:2 [ "nombre" => "O." "apellidos" => "Leiva Galvis" ] ] "afiliaciones" => array:2 [ 0 => array:1 [ "entidad" => "Servicio de Urología. Hospital 12 de Octubre. Madrid" ] 1 => array:1 [ "entidad" => "Actas Urol Esp 2005; 29 (6): 535-541" ] ] "correspondencia" => array:1 [ 0 => array:3 [ "identificador" => "cor0005" "etiqueta" => "1" "correspondencia" => "Dr. C. García Peñalver Villarta de los Montes, 33 06800 Mérida (Badajoz)" ] ] ] ] "titulosAlternativos" => array:1 [ "en" => array:1 [ "titulo" => "Clinical usefulness of the immunocyt<span class="elsevierStyleSup">TM</span> urinary test in the follow-up protocol of patients with urothelial neoplasms" ] ] "pdfFichero" => "main.pdf" "tienePdf" => true "fechaRecibido" => "2005-02-23" "PalabrasClave" => array:2 [ "es" => array:1 [ 0 => array:4 [ "clase" => "keyword" "titulo" => "Palabras clave" "identificador" => "xpalclavsec87546" "palabras" => array:3 [ 0 => "Neoplasia vesical" 1 => "Cistoscopia" 2 => "Citología urinaria" ] ] ] "en" => array:1 [ 0 => array:4 [ "clase" => "keyword" "titulo" => "Key words" "identificador" => "xpalclavsec87545" "palabras" => array:3 [ 0 => "Bladder cancer" 1 => "Cystoscopy" 2 => "Urinary cytology" ] ] ] ] "tieneResumen" => true "resumen" => array:2 [ "es" => array:2 [ "titulo" => "Resumen" "resumen" => "<span class="elsevierStyleSectionTitle">Objectivos</span><p id="spar0005" class="elsevierStyleSimplePara elsevierViewall">El objetivo global de este trabajo es el de determinar en un estudio prospectivo la utilidad del kit comercial IMMNUNOCYT‘ para el seguimiento de pacientes tratados de cáncer de vejiga y la evaluación de su utilidad como complemento de la citología urinaria y posible herramienta en la reducción del número de cistoscopias de revisión.</p> <span class="elsevierStyleSectionTitle">Material y Métodos</span><p id="spar0010" class="elsevierStyleSimplePara elsevierViewall">Entre Septiembre/01 a Diciembre/02 se recogió la orina de un total de 136 pacientes (115 con antecedentes de neoplasia vesical o sospecha de la misma y 21 pacientes con otras patologías urológicas) para realizarles el test del InmunoCyt® (uCyt+) y la citología urinaria. La orina recogida era fijada con alcohol al 50% en un volumen igual. La citología urinaria y el InmunoCyt® fueron informados por un citopatólogo que desconocía tanto el resultado de su correspondiente citología como el informe de la biopsia vesical. Para el estadiaje y grado de las muestras se utilizaron la clasificación TNM de la UICC de 1997 y la de la WHO/ISUP de 1998. Se dispuso de confirmación histopatológica de las lesiones en 111 pacientes (81,6% de los pacientes).</p> <span class="elsevierStyleSectionTitle">Resultados</span><p id="spar0015" class="elsevierStyleSimplePara elsevierViewall">La distribución por sexos fue del 89% para varones y del 11% mujeres. La edad media fue de 71,68 años [27-98]. La sensibilidad y especificidad globales fueron del 77,9% y 92,3% para el InmunoCyt® y del 47,9% y 100% para la citología urinaria respectivamente. Los valores predictivos positivos (VPP) y negativos (VPN) fueron del 96,4% y 61,7% respectivamente para el InmunoCyt® y del 100% y 36,7% para la citología. En los Ta y carcinomas de bajo grado la sensibilidad del InmunoCyt® fue del 70% (n=20) y 76,4% (n=34) respectivamente, mientras que para la citología urinaria fue del 25% (n=28) y 29,7% (n=37) respectivamente. Las diferencias observadas entre las sensibilidades del InmunoCyt® y de su citología fueron estadísticamente significativas (X2 p<0,05) tanto de forma global como en los Ta y en los ca. de bajo grado. La sensibilidad y especificidad conjunta de los dos test (ambos test combinados) fue del 86,8% y 96,2% respectivamente. La sensibilidad conjunta de los dos test para los Ta y bajo grado fue del 80% (n=20) y del 82,3% (n=34) respectivamente. Con el InmunoCyt® se diagnosticó de forma global un 36,2% de tumores.</p> <span class="elsevierStyleSectionTitle">Conclusiones</span><p id="spar0020" class="elsevierStyleSimplePara elsevierViewall">A la vista de los resultados obtenidos decidimos cambiar nuestro protocolo de seguimiento reduciendo el número de cistoscopias en las revisiones al 32,2% durante los 5 primeros años de seguimiento tras la cirugía (sobre una cohorte de 140 pacientes intervenidos anualmente). Esto supondrá un beneficio para el paciente ya que disminuirán el número de infecciones urinarias y la iatrogenia ocasionadas por la realización de las cistoscopias de seguimiento. Además, esta reducción del 32,2% del número de cistoscopias en 5 años reportará un ahorro sanitario aproximado de 35.560 en 5 años.</p>" ] "en" => array:2 [ "titulo" => "Abstract" "resumen" => "<span class="elsevierStyleSectionTitle">Objectives</span><p id="spar0025" class="elsevierStyleSimplePara elsevierViewall">The overall objective of this study was to carry out a prospective investigation of the usefulness of the IMMUNOCYT<span class="elsevierStyleSup">TM</span> commercial kit in the follow-up of patients treated for bladder cancer and to evaluate its utility as a complement to urinary cytology and a possible tool for reducing the number of follow-up cystoscopies required.</p> <span class="elsevierStyleSectionTitle">Subjects and methods</span><p id="spar0030" class="elsevierStyleSimplePara elsevierViewall">From September 2001 to December 2002, the ImmunoCyt<span class="elsevierStyleSup">TM</span> test and urinary cytology were performed in urine simples from a total of 136 patients (115 with a history or suspicion of bladder cancer and 21 patients with other urological pathologies). Urine simples were fixed with an equal volume of 50% alcohol. Urinary cytology and the ImmunoCyt<span class="elsevierStyleSup">TM</span> test were interpreted by a cytopathologist unacquainted with the result of the corresponding cytology and bladder biopsy report. Samples were staged and graded using the 1997 TNM classification of the UICC and the 1998 WHO/ISUP classification. Histopathological confirmation of lesions was available for 111 patients (81.6%).</p> <span class="elsevierStyleSectionTitle">Results</span><p id="spar0035" class="elsevierStyleSimplePara elsevierViewall">The gender distribution was 89% men and 11% women. Mean age was 71.68 years (range 27 to 98 years). Overall sensitivity and specificity were 77.9% and 92.3% for the ImmunoCyt<span class="elsevierStyleSup">TM</span> test and 47.9% and 100% for urinary cytology, respectively. The positive (PPV) and negative predictive values (NPV) were 96.4% and 61.7%, respectively, for the ImmunoCyt<span class="elsevierStyleSup">TM</span> test and 100% and 36.7% for cytology. In Ta and low-grade carcinomas, the sensitivity of the ImmunoCyt<span class="elsevierStyleSup">TM</span> test was 70% (n=20) and 76.4% (n=34) respectively, whereas it was 25% (n=28) and 29.7% (n=37), respectively, for urinary cytology. The differences observed between the sensitivities of the ImmunoCyt<span class="elsevierStyleSup">TM</span> test and cytology were statistically significant (X2 p<0.05) overall and for Ta and low-grade carcinomas. The sensitivity and specificity of the combination of both tests were 86.8% and 96.2%, respectively. The sensitivity of the combination of both tests for Ta and low-grade carcinomas was 80% (n=20) and 82.3% (n=34), respectively. The ImmunoCyt<span class="elsevierStyleSup">TM</span> test was diagnostic in 36.2% of tumors overall.</p> <span class="elsevierStyleSectionTitle">Conclusions</span><p id="spar0040" class="elsevierStyleSimplePara elsevierViewall">In view of the results obtained, we decided to change our follow-up protocol to reduce the number of follow-up cystoscopies by 32.2% in the first 5 years of postoperative follow-up (in a cohort of 140 patients who undergo surgery annually). This benefits patients by reducing the number of urinary infections and iatrogenesis originated by follow-up cystoscopy. In addition, this 32.2% reduction in the number of cystoscopies in 5 years will yield a savings of approximately 35,560 EUR to the health care system in 5 years.</p>" ] ] "bibliografia" => array:2 [ "titulo" => "Bibliografía" "seccion" => array:1 [ 0 => array:2 [ "identificador" => "bibs0005" "bibliografiaReferencia" => array:13 [ 0 => array:3 [ "identificador" => "bib0005" "etiqueta" => "1." "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Morbidity following cystoscopy: comparison of flexible and rigid techniques" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:3 [ 0 => "S.W. Denholin" 1 => "I.G. Conn" 2 => "J.E. Newsam" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:5 [ "tituloSerie" => "Br J Urol" "fecha" => "1990" "volumen" => "66" "paginaInicial" => "152" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/2390702" "web" => "Medline" ] ] ] ] ] ] ] ] 1 => array:3 [ "identificador" => "bib0010" "etiqueta" => "2." "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Development of nosocomial and iatrogenic urinary tract infections (UTI) following urological interventions. A prospective clínical study" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:3 [ 0 => "M. Westenfelder" 1 => "K. Rosset" 2 => "Y. Pelz" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:4 [ "tituloSerie" => "Scand J Neplirol, Suppl" "fecha" => "1987" "volumen" => "104" "paginaInicial" => "59" ] ] ] ] ] ] 2 => array:3 [ "identificador" => "bib0015" "etiqueta" => "3." "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Immnunocyt a useful method in the follow-up protocol for Urol patients with urinary bladder carcinoma" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:2 [ 0 => "H. Olsson" 1 => "B. Zackrisson" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:7 [ "tituloSerie" => "Scand J Urol Nephrol" "fecha" => "2001" "volumen" => "35" "numero" => "4" "paginaInicial" => "280" "paginaFinal" => "282" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/11676352" "web" => "Medline" ] ] ] ] ] ] ] ] 3 => array:3 [ "identificador" => "bib0020" "etiqueta" => "4." "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Noninvasive detection of bladder cancer with the BTA stat test" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:3 [ 0 => "D. Pode" 1 => "A. Shapiro" 2 => "M. Wald" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:6 [ "tituloSerie" => "J Urol" "fecha" => "1999" "volumen" => "161" "paginaInicial" => "443" "paginaFinal" => "446" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/9915422" "web" => "Medline" ] ] ] ] ] ] ] ] 4 => array:3 [ "identificador" => "bib0025" "etiqueta" => "5." "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "The early detection and diagnosis of bladder cancer: a critical review of the options" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:3 [ 0 => "A. Saad" 1 => "D.C. Hanbury" 2 => "T.A. McNicholas" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "52519" "Revista" => array:5 [ "tituloSerie" => "Eur Urol" "fecha" => "2001" "volumen" => "39" "paginaInicial" => "619" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/11464050" "web" => "Medline" ] ] ] ] ] ] ] ] 5 => array:3 [ "identificador" => "bib0030" "etiqueta" => "6." "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Bladder cancer II. Molecular aspects and dignosis" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:2 [ 0 => "I. Kausch" 1 => "A. Böhle" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "52495" "Revista" => array:7 [ "tituloSerie" => "Eur Urol" "fecha" => "2001" "volumen" => "39" "numero" => "5" "paginaInicial" => "498" "paginaFinal" => "506" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/11464029" "web" => "Medline" ] ] ] ] ] ] ] ] 6 => array:3 [ "identificador" => "bib0035" "etiqueta" => "7." "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Superficial bladder tumors" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:2 [ 0 => "D.K. Chopin" 1 => "B. Gattegno" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:7 [ "tituloSerie" => "Eur Urol" "fecha" => "2002" "volumen" => "42" "numero" => "6" "paginaInicial" => "533" "paginaFinal" => "541" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/12477647" "web" => "Medline" ] ] ] ] ] ] ] ] 7 => array:3 [ "identificador" => "bib0040" "etiqueta" => "8." "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Diagnostic efficacy of the Immnunocyt test to detect superficial bladder cancer recurrence" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:3 [ 0 => "J.L. Vriesema" 1 => "F. Atsma" 2 => "L.A. Kiemeney" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:7 [ "tituloSerie" => "Urology" "fecha" => "2001" "volumen" => "58" "numero" => "3" "paginaInicial" => "367" "paginaFinal" => "371" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/11549482" "web" => "Medline" ] ] ] ] ] ] ] ] 8 => array:3 [ "identificador" => "bib0045" "etiqueta" => "9." "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Immnunocyt test improves the diagnostic accuracy of urinary cytology: Results of a Frech multicenter study" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:3 [ 0 => "C. Pfister" 1 => "D. Chautard" 2 => "M. Devonec" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1097/01.ju.0000048983.83079.4c" "Revista" => array:7 [ "tituloSerie" => "J Urol" "fecha" => "2003" "volumen" => "169" "numero" => "3" "paginaInicial" => "921" "paginaFinal" => "924" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/12576813" "web" => "Medline" ] ] ] ] ] ] ] ] 9 => array:3 [ "identificador" => "bib0050" "etiqueta" => "10." "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Performances characteristics of a new monoclonal antibody test for bladder cancer: Immnunocyt" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:2 [ 0 => "Y. Fradet" 1 => "C. Lockhart" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:5 [ "tituloSerie" => "Canad J Urol" "fecha" => "1997" "volumen" => "4" "paginaInicial" => "400" "paginaFinal" => "405" ] ] ] ] ] ] 10 => array:3 [ "identificador" => "bib0055" "etiqueta" => "11." "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Immnunocyt a new tool for detecting transitional cell cancer of the urinary tract" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:3 [ 0 => "C. Mian" 1 => "A. Pycha" 2 => "H. Wiener" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:6 [ "tituloSerie" => "J Urol" "fecha" => "1999" "volumen" => "161" "paginaInicial" => "1486" "paginaFinal" => "1489" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/10210378" "web" => "Medline" ] ] ] ] ] ] ] ] 11 => array:3 [ "identificador" => "bib0060" "etiqueta" => "12." "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Recent advances in the management of superficial bladder tumors" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:1 [ 0 => "Y. Fradet" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:7 [ "tituloSerie" => "The Canadian Journal of Urology" "fecha" => "2002" "volumen" => "9" "numero" => "3" "paginaInicial" => "1544" "paginaFinal" => "1644" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/12121579" "web" => "Medline" ] ] ] ] ] ] ] ] 12 => array:3 [ "identificador" => "bib0065" "etiqueta" => "13." "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Comparison of molecular and convencional strategies for followup of superficial bladder cancer using decision analysis" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:3 [ 0 => "R.K. Nam" 1 => "D.A. Redelmeier" 2 => "P.E. Spiess" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:6 [ "tituloSerie" => "J Urol" "fecha" => "2000" "volumen" => "163" "paginaInicial" => "752" "paginaFinal" => "757" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/10687970" "web" => "Medline" ] ] ] ] ] ] ] ] ] ] ] ] ] "idiomaDefecto" => "es" "url" => "/02104806/0000002900000006/v1_201304251755/S0210480605732939/v1_201304251755/es/main.assets" "Apartado" => array:4 [ "identificador" => "6429" "tipo" => "SECCION" "es" => array:2 [ "titulo" => "Original" "idiomaDefecto" => true ] "idiomaDefecto" => "es" ] "PDF" => "https://static.elsevier.es/multimedia/02104806/0000002900000006/v1_201304251755/S0210480605732939/v1_201304251755/es/main.pdf?idApp=UINPBA00004N&text.app=https://www.elsevier.es/" "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S0210480605732939?idApp=UINPBA00004N" ]
Journal Information
Utilidad clínica del test urinario ImmunocytTM en el protocolo de revisiones de pacientes con antecedentes de neoplasia uroteliales
Clinical usefulness of the immunocytTM urinary test in the follow-up protocol of patients with urothelial neoplasms
Servicio de Urología. Hospital 12 de Octubre. Madrid
Actas Urol Esp 2005; 29 (6): 535-541